The long-term effects of amphetamine sulfate (5 mg AM and lunchtime, increasing to a mean dose of 17 mg/d, 0.52 mg/kg body weight, and a maximum of 45 mg/d) were evaluated in 62 children, aged 6 to 11 years, with ADHD treated for 15 months in a randomized, double-blind, placebo-controlled study at the Child and Adolescent Psychiatry University departments in Goteborg, Uppsala, Malmo-Lund, and Umea, Sweden
Methylphenidate (MPH), the most common medication for children with Attention Deficit/Hyperactivity ...
Mixed amphetamine salts extended release (MAS XR; Adderall XR®) and atomoxetine (Strattera®) were co...
Once-daily osmotic controlled-release (OROS) methylphenidate (Concerta) in the treatment of 407 chil...
Attention-deficit hyperactivity disorder (ADHD) is a neurobehavioral disorder affecting approximatel...
Psychostimulants such as methylphenidate belong to the treatment of first choice in multimodal inter...
Background. Methodological and ethical constraints have hampered studies into long-term lasting outc...
Background: Methodological and ethical constraints have hampered studies into long-term lasting outc...
The long-term tolerability and effectiveness of extended release mixed amphetamine salts (Adderall X...
Background There are persistent concerns of long-term effects of stimulant ADHD medication on the de...
Background: Methylphenidate is the most frequently prescribed medication for the treatment of ADHD i...
National survey data suggest a steady increase in the diagnosis and treatment of mental disorders in...
textabstractStimulant prescription rates for attention deficit hyperactivity disorder (ADHD) are inc...
Stimulant prescription rates for attention deficit hyperactivity disorder (ADHD) are increasing, eve...
Attention deficit hyperactivity disorder (ADHD) is a frequently diagnosed and treated behavioral dis...
Attention-deficit/hyperactivity disorder (ADHD), one of the most common neuropsychiatric conditions ...
Methylphenidate (MPH), the most common medication for children with Attention Deficit/Hyperactivity ...
Mixed amphetamine salts extended release (MAS XR; Adderall XR®) and atomoxetine (Strattera®) were co...
Once-daily osmotic controlled-release (OROS) methylphenidate (Concerta) in the treatment of 407 chil...
Attention-deficit hyperactivity disorder (ADHD) is a neurobehavioral disorder affecting approximatel...
Psychostimulants such as methylphenidate belong to the treatment of first choice in multimodal inter...
Background. Methodological and ethical constraints have hampered studies into long-term lasting outc...
Background: Methodological and ethical constraints have hampered studies into long-term lasting outc...
The long-term tolerability and effectiveness of extended release mixed amphetamine salts (Adderall X...
Background There are persistent concerns of long-term effects of stimulant ADHD medication on the de...
Background: Methylphenidate is the most frequently prescribed medication for the treatment of ADHD i...
National survey data suggest a steady increase in the diagnosis and treatment of mental disorders in...
textabstractStimulant prescription rates for attention deficit hyperactivity disorder (ADHD) are inc...
Stimulant prescription rates for attention deficit hyperactivity disorder (ADHD) are increasing, eve...
Attention deficit hyperactivity disorder (ADHD) is a frequently diagnosed and treated behavioral dis...
Attention-deficit/hyperactivity disorder (ADHD), one of the most common neuropsychiatric conditions ...
Methylphenidate (MPH), the most common medication for children with Attention Deficit/Hyperactivity ...
Mixed amphetamine salts extended release (MAS XR; Adderall XR®) and atomoxetine (Strattera®) were co...
Once-daily osmotic controlled-release (OROS) methylphenidate (Concerta) in the treatment of 407 chil...